# A Prospective Clinical Study Aimed to Assess the Technical Feasibility of RR2 Wearable Home Care Neuromodulation System

> **NCT04580953** · NA · COMPLETED · sponsor: **Ziv HealthCare Ltd.** · enrollment: 11 (actual)

## Conditions studied

- Atrial Fibrillation Recurrence

## Interventions

- **DEVICE:** CardiaCareTM RR2

## Key facts

- **NCT ID:** NCT04580953
- **Lead sponsor:** Ziv HealthCare Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-28
- **Primary completion:** 2022-01-02
- **Final completion:** 2022-01-02
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2022-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04580953

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04580953, "A Prospective Clinical Study Aimed to Assess the Technical Feasibility of RR2 Wearable Home Care Neuromodulation System". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04580953. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*